La. Admin. Code tit. 46 § LIII-2929
Current through Register Vol. 50, No. 11, November 20, 2024
Section LIII-2929 - Program EvaluationA. The board shall, in consultation with and upon recommendation of the advisory council, design and implement an evaluation component to identify cost benefits of the prescription monitoring program and other information relevant to policy, research, and education involving controlled substances and drug monitored by the prescription monitoring program.La. Admin. Code tit. 46, § LIII-2929
Promulgated by the Department of Health and Hospitals, Board of Pharmacy, LR 33:1348 (July 2007).AUTHORITY NOTE: Promulgated in accordance with R.S. 40:1011.